Best of ASCO - 2014 Annual Meeting

 

Welcome

Cancer Prevention

Cancer Prevention, Hereditary Genetics, and Epidemiology

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A comparison of risk factors for cigarette and e-cigarette use in the United States adult population.

Leo Chen

1546

A non-interventional, multicenter study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal, and fallopian tube cancer patients in India.

Rohit Kodagali

e13073

An analysis of the sociodemographic factors contributing to patient nonadherence to recommendations for screening mammograms.

Ahmer Mohammad Ansari

e13077

Analysis of healthy breast tissue from Komen Tissue Bank shows distinct histology, decreased proliferation, and lower periductal collagen deposition in women with prolonged history of breastfeeding.

Mustafa Basree

1538

Antiviral therapy to reduce hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial.

Gang Huang

1510

Assessment of breast cancer risk in BRCA carriers with ovarian cancer: Evaluation of data from longitudinal observation.

Tamar Safra

e13062

Breast Cancer Cases in a Surveillance Program: Report from the Hereditary Department at South General Hospital, Sweden.

Anna-Maria Karumo

e13068

Colorectal cancer: Improving screening in a rural clinic.

Thuy Thanh Thi Le

e13054

Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes.

Zachary Phillip Schwartz

1547

Complex multimorbidity, perceived life expectancy, and routine cancer screening receipt: Differences between older women and men.

Siran M. Koroukian

e13071

Data from an integrated cancer prevention center screening for multiple cancer types.

Ezra Bernstein

e13069

Demographic characteristics of smoldering multiple myeloma patients: A hospital-based study including 11,643 patients.

Kamal Chamoun

e13064

Design and implementation of an Internet-based cancer risk assessment tool: Use over 10 years.

Michael Joseph Lariviere

e13075

Development of a plasma cell-free DNA chromosome instabilities assay for early cancer detection and treatment response monitoring of multiple tumor types.

Yang Yang

e13072

Diagnosis of lung cancer by canine olfactory detection in urine and breath samples.

Charlotte Feil

e13067

Effect modifiers in a randomized phase III trial of low-dose tamoxifen in breast preinvasive disease.

Andrea De Censi

1500

Effectiveness of low-dose CT scan for lung cancer screening in the community setting.

Jason Aboudi Mouabbi

1543

HPV test self collection versus CO-testing (2015-2018): New experience in a screening program in a northern province of Argentina, Tucumán.

Juan Jose Zarba

e13063

Impact of a breast cancer (BC) polygenic risk score (PRS) on the decision to take preventive endocrine therapy (ET): The Genetic Risk Estimate (GENRE) trial.

Julian Oliver Kim

1501

Implementation of a low-dose computerized tomography (LDCT) lung cancer screening program (LCSP) across a large integrated health system.

Marija Bjegovich-Weidman

1537

Implementation of HPV vaccination pilot project in Kazakhstan: Successes and challenges.

Dilyara Kaidarova

e13056

Improving risk assessment of obesity-associated breast cancer.

Neil M. Iyengar

1544

Low-fat dietary pattern and breast cancer mortality by metabolic syndrome degree: Secondary analyses of the Women’s Health Initiative (WHI) Dietary Modification randomized trial.

Kathy Pan

1539

Lung cancer: Improving screening in rural clinic.

Thuy Thanh Thi Le

e13060

Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns.

Catherine H. Watson

1536

New onset diabetes as a predictive factor of focal lesions in the pancreas in a high-risk screening program.

Maria Fernanda Montiel

1512

Omega-3 fatty acids and ERPR(-) and HER2/neu(+/-) breast cancer prevention.

Chidimma Kalu

TPS1589

Opportunistic off-target cancer screening in organized programs: The EDIFICE 6 survey.

Jean F. Morere

1535

Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery.

Katrina Alber

TPS1588

Primary prevention and smoking habit among BRCA1/2 mutation carriers.

Patricia Cordeiro

e13061

Prognostic significance of blood-based cancer detection in plasma cell-free DNA (cfDNA): Evaluating risk of overdiagnosis.

Geoffrey R. Oxnard

1545

Protamine sulfate may prevent infections by pathogens that require heparan sulfate proteoglycan interactions, including high- and low-risk Human Papillomaviruses and Chlamydia trachomatis..

Ricardo Gomez

e13065

Radiomics analysis for pathological classification prediction in BI-RADS category 4 mammographic calcifications.

Chu-qian Lei

e13055

Risk of colon adenoma in patients with breast cancer.

Yinghong Wang

1541

Risk of colonic adenoma in patients with non–colorectal cancers.

Hamzah Abu-Sbeih

e13070

Role of vitamin D supplementation for primary prevention of cancer: Meta-analysis of randomized controlled trials.

Varun Samji

1534

Safety and efficacy of aspirin for primary prevention of cancer: A meta-analysis of randomized controlled trials.

Tarek Haykal

1533

The impact of smoking cessation on breast cancer patients’ survival.

Mazen Jizzini

1542

The results of colorectal cancer screening in the Republic of Kazakhstan during the period from 2013 to 2018.

Dilyara Kaidarova

e13074

Utilizing social media for cancer prevention.

Ana Maria Lopez

e13076

Whole exome sequencing of germline DNA of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung adenocarcinoma (LUAD) according to KRAS status.

Jose Luis Perez-Gracia

1540